ArticleBMC veterinary research2026
Molecular characterization of Eimeria necatrix surface antigen SAG8 and SAG36 genes and their immunoprotective efficacy in chicken.
Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundSurface antigens (SAGs) are a class of membrane proteins anchored to the parasite surface via glycosylphosphatidylinositol (GPI) anchors. These antigens play critical roles in parasite adhesion and host cell invasion. However, studies on SAGs from Eimeria necatrix remain limited.
resultsIn this study, two sag genes, which exhibit differential expression in SZ and MZ-2 stages of E. necatrix, were cloned and expressed. The Ensag8 (XM_013584257.1) and Ensag36 (XM_013577436.1) genes, encoding proteins of 263 and 265 amino acids with predicted molecular weights of 27.83 kDa and 28.66 kDa, respectively. Bioinformatic analysis indicated that neither protein contains transmembrane domains, and phylogenetic classification placed both within the SAGA sub-family, with EnSAG8 showing close evolutionary proximity to EtSAG8. Recombinant proteins rEnSAG8 and rEnSAG36 were expressed predominantly as inclusion bodies in Escherichia coli, with apparent molecular weights of approximately 32 kDa and 36 kDa, respectively. Both rEnSAG8 and rEnSAG36 were recognized by a mouse anti-His tag monoclonal antibody and by convalescent serum from chickens infected with E. necatrix and E. tenella. The native EnSAG8 protein was detected in MZ-2 with an observed molecular weight of ~ 35 kDa, and EnSAG36 was detected in both SZ and MZ-2 at ~ 36 kDa. Immunolocalization analysis revealed that both native proteins are localized on the membranes of SZ and MZ-2. Transcriptional analysis indicated that Ensag8 is more highly expressed in MZ-2 than in SZ, whereas Ensag36 shows higher transcriptional levels in SZ than in MZ-2. Following the E. necatrix challenge, the anticoccidial index (ACI) of both the rEnSAG8- and rEnSAG36-immunized groups exceeded 160 at an immunization dose of 100 µg per chicken per immunization, with the rEnSAG8 group achieving a higher ACI than the rEnSAG36 group. Combined immunization with rEnSAG8 and rEnSAG36 conferred greater protection than immunization with either antigen alone.
conclusionsThis study provides insights into the characterization of SAGs from E. necatrix. The differential expression of Ensag8 and Ensag36 highlights their potential roles in different parasite stages. Immunization with these recombinant proteins demonstrated significant anticoccidial protection, with combined immunization offering the best results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.